Amneal Enters U.S. Biosimilars Market With Approval of RELEUKO (filgrastim-ayow)
Amneal Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) approval of the Biologics License ...
Read more
Tag: Biosimilar
Lupin announces U.S. FDA acceptance for Pegfilgrastim Biosimilar application
Lupin Limited announced that the U.S. FDA has accepted the Biologics License Application (BLA) for its ...
Read more
Seagen and Astellas Announce U.S. FDA Acceptance of Two Supplemental Biologics License Applications
- Priority Review Granted with Action Date of August 17 - - Australia and Canada Regulators ...
Read more